142 related articles for article (PubMed ID: 34394109)
1. Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma.
Xu QQ; Li QJ; Huang CL; Cai MY; Zhang MF; Yin SH; Lu LX; Chen L
Front Immunol; 2021; 12():708293. PubMed ID: 34394109
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
Meng J; Zhang J; Xiu Y; Jin Y; Xiang J; Nie Y; Fu S; Zhao K
Mol Oncol; 2018 Feb; 12(2):196-207. PubMed ID: 29160958
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment outcomes and prognosis of mucosal melanoma of the head and neck: 161 cases from a single institution.
Sun S; Huang X; Gao L; Zhang Y; Luo J; Zhang S; Wang K; Qu Y; Wu R; Liu Q; Xiao J; Xu G; Yi J
Oral Oncol; 2017 Nov; 74():115-122. PubMed ID: 29103739
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities.
Xu QQ; Lai YZ; Huang ZL; Zeng ZY; Zhang YN; Ou RY; Wu WM; Chen L; Lu LX
Radiat Oncol; 2021 Jul; 16(1):138. PubMed ID: 34321026
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
Front Immunol; 2022; 13():835630. PubMed ID: 35401554
[TBL] [Abstract][Full Text] [Related]
6. A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma.
Li Y; Lu S; Lan M; Peng X; Zhang Z; Lang J
J Transl Med; 2020 Jun; 18(1):223. PubMed ID: 32503630
[TBL] [Abstract][Full Text] [Related]
7. A nomogram for predicting survival of head and neck mucosal melanoma.
Xu QQ; Li QJ; Chen L; Su XY; Song JX; Du J; Chen L; Lu LX
Cancer Cell Int; 2021 Apr; 21(1):224. PubMed ID: 33865388
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma.
Xu QQ; Li QJ; Xu Z; Lan LL; Hou Z; Liu J; Lu L; Chen YY; Chen RZ; Wen X
Front Immunol; 2023; 14():1076890. PubMed ID: 36911694
[TBL] [Abstract][Full Text] [Related]
9. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival in mucosal melanoma of the head and neck.
Jethanamest D; Vila PM; Sikora AG; Morris LG
Ann Surg Oncol; 2011 Oct; 18(10):2748-56. PubMed ID: 21476106
[TBL] [Abstract][Full Text] [Related]
11. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.
Jurmeister P; Bockmayr M; Treese C; Stein U; Lenze D; Jöhrens K; Friedling F; Dietel M; Klauschen F; Marsch W; Fiedler E; von Laffert M
J Dtsch Dermatol Ges; 2019 Aug; 17(8):800-808. PubMed ID: 31437373
[TBL] [Abstract][Full Text] [Related]
13. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
[TBL] [Abstract][Full Text] [Related]
14. Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck.
Thierauf J; Veit JA; Lennerz JK; Weissinger SE; Affolter A; Döscher J; Bergmann C; Knopf A; Grünow J; Grünmüller L; Mauch C; Plinkert PK; Hoffmann TK; Hess J
Head Neck Pathol; 2017 Sep; 11(3):314-320. PubMed ID: 27844409
[TBL] [Abstract][Full Text] [Related]
15. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
16. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
Yuan Y; Ren J; Shi Y; Tao X
Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of an Immunohistochemical Signature in Patients With Bladder Cancer Undergoing Radical Cystectomy.
Wu J; Wen JM; Wang YC; Luo WJ; Wang QF; Lv H; Dai B; Ye DW; Su HC; Zhu YP
Front Oncol; 2021; 11():641385. PubMed ID: 33842349
[TBL] [Abstract][Full Text] [Related]
18. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
19. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
Tian J; Yang Y; Li MY; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
